X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7147) 7147
Book Review (886) 886
Publication (412) 412
Newsletter (57) 57
Magazine Article (49) 49
Book Chapter (21) 21
Conference Proceeding (13) 13
Trade Publication Article (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6109) 6109
humans (5452) 5452
doxycycline - therapeutic use (4370) 4370
male (3234) 3234
female (2945) 2945
anti-bacterial agents - therapeutic use (2690) 2690
doxycycline (2665) 2665
adult (2162) 2162
animals (1955) 1955
middle aged (1700) 1700
doxycycline - administration & dosage (998) 998
treatment outcome (998) 998
aged (939) 939
infectious diseases (937) 937
doxycycline - pharmacology (934) 934
adolescent (809) 809
abridged index medicus (693) 693
pharmacology & pharmacy (679) 679
antibiotics (663) 663
microbiology (658) 658
mice (645) 645
anti-bacterial agents - administration & dosage (595) 595
drug therapy, combination (571) 571
medicine, general & internal (478) 478
health aspects (466) 466
child (463) 463
dentistry (457) 457
anti-bacterial agents - pharmacology (450) 450
infections (441) 441
diagnosis (432) 432
immunology (419) 419
research (412) 412
therapy (409) 409
drug therapy (397) 397
time factors (384) 384
analysis (377) 377
care and treatment (377) 377
tetracycline (372) 372
administration, oral (357) 357
doxycycline - adverse effects (354) 354
diagnosis, differential (351) 351
disease (349) 349
tetracyclines (349) 349
infection (344) 344
dermatology (339) 339
follow-up studies (325) 325
rats (324) 324
dentistry, oral surgery & medicine (318) 318
brucellosis - drug therapy (311) 311
risk factors (304) 304
rifampin - therapeutic use (302) 302
expression (300) 300
chlamydia infections - drug therapy (285) 285
microbial sensitivity tests (282) 282
disease models, animal (272) 272
retrospective studies (271) 271
minocycline (262) 262
prospective studies (262) 262
double-blind method (255) 255
azithromycin (253) 253
young adult (253) 253
veterinary sciences (252) 252
research article (245) 245
gene expression (241) 241
in-vitro (239) 239
dogs (238) 238
pregnancy (235) 235
medicine (234) 234
azithromycin - therapeutic use (232) 232
anti-infective agents - therapeutic use (230) 230
surgery (228) 228
article (227) 227
bacteria (226) 226
lyme disease - drug therapy (226) 226
multidisciplinary sciences (223) 223
child, preschool (222) 222
anti-bacterial agents - adverse effects (217) 217
oncology (216) 216
inflammation (214) 214
matrix metalloproteinases (214) 214
tetracycline - therapeutic use (212) 212
travel (210) 210
dosage and administration (207) 207
dose-response relationship, drug (207) 207
aged, 80 and over (206) 206
acute disease (205) 205
antibodies, bacterial - blood (204) 204
polymerase chain reaction (202) 202
efficacy (199) 199
clinical trials as topic (197) 197
drugs (194) 194
cancer (192) 192
chronic disease (192) 192
antimalarials - therapeutic use (191) 191
medicine, research & experimental (189) 189
proteins (189) 189
drug resistance (187) 187
medicine & public health (186) 186
inhibition (185) 185
recurrence (185) 185
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6483) 6483
French (200) 200
German (190) 190
Spanish (104) 104
Russian (62) 62
Dutch (38) 38
Japanese (36) 36
Polish (28) 28
Italian (24) 24
Turkish (19) 19
Hungarian (14) 14
Chinese (12) 12
Norwegian (12) 12
Finnish (10) 10
Swedish (9) 9
Czech (7) 7
Danish (7) 7
Portuguese (5) 5
Hebrew (4) 4
Korean (3) 3
Bulgarian (2) 2
Ukrainian (2) 2
Croatian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Experimental Eye Research, ISSN 0014-4835, 2006, Volume 83, Issue 3, pp. 526 - 535
We investigated the effects of corticosteroid and doxycycline on expression of matrix metalloproteinase (MMP)-9 and inflammatory cytokines and activation of... 
mouse | matrix metalloproteinase 9 | ocular surface | anti-inflammatory | methylprednisolone | mitogen-activated protein kinase signaling pathway | dry eye | doxycycline | corneal epithelium | TRANSCRIPTION FACTORS | JNK PATHWAYS | TEAR FLUID | SJOGRENS-SYNDROME | MATRIX METALLOPROTEINASES | KERATOCONJUNCTIVITIS SICCA | GENE-EXPRESSION | OPHTHALMOLOGY | ARTICULAR CHONDROCYTES | NF-KAPPA-B | Epithelium, Corneal - enzymology | Immunohistochemistry | Dry Eye Syndromes - immunology | Glucocorticoids - therapeutic use | Methylprednisolone - therapeutic use | Depression, Chemical | p38 Mitogen-Activated Protein Kinases - analysis | Dry Eye Syndromes - enzymology | Mitogen-Activated Protein Kinases - analysis | Scopolamine Hydrobromide | Anti-Inflammatory Agents - therapeutic use | Epithelium, Corneal - drug effects | Models, Animal | Epithelium, Corneal - immunology | Permeability - drug effects | Interleukin-1 - analysis | Doxycycline - therapeutic use | Dry Eye Syndromes - drug therapy | Mice, Inbred C57BL | Matrix Metalloproteinase 9 - analysis | JNK Mitogen-Activated Protein Kinases - analysis | Tumor Necrosis Factor-alpha - analysis | Microscopy, Confocal | Animals | MAP Kinase Signaling System - drug effects | Mice | Messenger RNA | Corticosteroids | Cytokines | Doxycycline | Epithelium | Methylprednisolone | Protein kinases | Index Medicus
Journal Article
Journal of Endodontics, ISSN 0099-2399, 2009, Volume 35, Issue 11, pp. 1483 - 1490
Journal Article
Journal Article
Journal Article
Journal Article
APMIS, ISSN 0903-4641, 12/2015, Volume 123, Issue 12, pp. 1055 - 1060
In recent years, coagulase‐negative staphylococci such as S taphylococcus epidermidis have gained importance as nosocomial pathogens, especially in... 
Implant infection | doxycycline | Etest | synergy testing | prosthetic joint infection | Synergy testing | Prosthetic joint infection | Doxycycline | ORTHOPEDIC IMPLANTS | MANAGEMENT | COMBINATION THERAPY | FUSIDIC ACID | DEBRIDEMENT | MICROBIOLOGY | RIFAMPICIN | IMMUNOLOGY | PATHOLOGY | IN-VITRO | SYNERGY | TIME-KILL | Staphylococcus epidermidis - drug effects | Joint Prosthesis - microbiology | Linezolid - therapeutic use | Humans | Biofilms - growth & development | Cross Infection | Prosthesis-Related Infections - drug therapy | Clindamycin - pharmacology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - microbiology | Drug Resistance, Multiple, Bacterial | Linezolid - pharmacology | Rifampin - therapeutic use | Staphylococcal Infections - microbiology | Fusidic Acid - pharmacology | Biofilms - drug effects | Staphylococcal Infections - drug therapy | Staphylococcus epidermidis - isolation & purification | Doxycycline - therapeutic use | Ciprofloxacin - therapeutic use | Ciprofloxacin - pharmacology | Clindamycin - therapeutic use | Fusidic Acid - therapeutic use | Doxycycline - pharmacology | Anti-Bacterial Agents - pharmacology | Rifampin - pharmacology | Implants, Artificial | Prosthesis | Staphylococcal infections | Disease susceptibility | Health aspects | Rifampin | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Implant infection; prosthetic joint infection; synergy testing; Etest; doxycycline
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 07/2015, Volume 86, Issue 7, pp. 705 - 705
Journal Article